Isomerase were approached by a biotech company looking to generate analogues of a known natural product peptide/polyketide, produced by a filamentous streptomycete bacteria.

• Solution: Strain improvement, USP and DSP development alongside bioengineering

Strain improvement was carried out via rational and classical approaches, alongside fermentation optimisation and DSP development. Titres (which were initially <0.01mg/L) reached the target required by the partner (>1g/L). Bioengineering on the strain was carried out to allow production of a range of related products, by feeding different small synthetic precursors. These were fermented, isolated and supplied for further activity and property testing.

If you would like to learn more about our capabilities then please get in contact with us here.